🚀 VC round data is live in beta, check it out!
Oxford Nanopore Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Oxford Nanopore Technologies and similar public comparables like SKAN Group, Enovis, Haier Biomedical, PROCEPT BioRobotics and more.
Oxford Nanopore Technologies Overview
About Oxford Nanopore Technologies
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Founded
2005
HQ
Employees
1.3K
Website
Financials (LTM)
EV
$1B
Oxford Nanopore Technologies Financials
Oxford Nanopore Technologies reported last 12-month revenue of $312M and negative EBITDA of ($184M).
In the same LTM period, Oxford Nanopore Technologies generated $187M in gross profit, ($184M) in EBITDA losses, and had net loss of ($186M).
Revenue (LTM)
Oxford Nanopore Technologies P&L
In the most recent fiscal year, Oxford Nanopore Technologies reported revenue of $245M and EBITDA of ($124M).
Oxford Nanopore Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $312M | XXX | $245M | XXX | XXX | XXX |
| Gross Profit | $187M | XXX | $141M | XXX | XXX | XXX |
| Gross Margin | 60% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | ($184M) | XXX | ($124M) | XXX | XXX | XXX |
| EBITDA Margin | (59%) | XXX | (51%) | XXX | XXX | XXX |
| EBIT Margin | (58%) | XXX | (83%) | XXX | XXX | XXX |
| Net Profit | ($186M) | XXX | ($195M) | XXX | XXX | XXX |
| Net Margin | (60%) | XXX | (80%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Oxford Nanopore Technologies' stock price is $1.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | (0.1%) | XXX | XXX | XXX | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOxford Nanopore Technologies Valuation Multiples
Oxford Nanopore Technologies trades at 3.5x EV/Revenue multiple, and (6.0x) EV/EBITDA.
EV / Revenue (LTM)
Oxford Nanopore Technologies Financial Valuation Multiples
As of March 7, 2026, Oxford Nanopore Technologies has market cap of $1B and EV of $1B.
Equity research analysts estimate Oxford Nanopore Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Oxford Nanopore Technologies has a P/E ratio of (8.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 3.5x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBITDA | (6.0x) | XXX | (8.8x) | XXX | XXX | XXX |
| EV/EBIT | (6.1x) | XXX | (5.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | 7.8x | XXX | XXX | XXX |
| P/E | (8.0x) | XXX | (7.6x) | XXX | XXX | XXX |
| EV/FCF | (9.1x) | XXX | (5.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Oxford Nanopore Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Oxford Nanopore Technologies Margins & Growth Rates
Oxford Nanopore Technologies' revenue in the last 12 month grew by 24%.
Oxford Nanopore Technologies' revenue per employee in the last FY averaged $0.2M.
Oxford Nanopore Technologies' rule of 40 is (35%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Oxford Nanopore Technologies' rule of X is 0% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Oxford Nanopore Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Margin | (59%) | XXX | (51%) | XXX | XXX | XXX |
| EBITDA Growth | (63%) | XXX | 67% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (35%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 0% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 87% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 41% | XXX | 54% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 141% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Oxford Nanopore Technologies Public Comps
See public comps and valuation multiples for other Life Sciences Tools and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SKAN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Enovis | XXX | XXX | XXX | XXX | XXX | XXX |
| Haier Biomedical | XXX | XXX | XXX | XXX | XXX | XXX |
| PROCEPT BioRobotics | XXX | XXX | XXX | XXX | XXX | XXX |
| Nolato | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Oxford Nanopore Technologies M&A Activity
Oxford Nanopore Technologies acquired XXX companies to date.
Last acquisition by Oxford Nanopore Technologies was on XXXXXXXX, XXXXX. Oxford Nanopore Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Oxford Nanopore Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOxford Nanopore Technologies Investment Activity
Oxford Nanopore Technologies invested in XXX companies to date.
Oxford Nanopore Technologies made its latest investment on XXXXXXXX, XXXXX. Oxford Nanopore Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Oxford Nanopore Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Oxford Nanopore Technologies
| When was Oxford Nanopore Technologies founded? | Oxford Nanopore Technologies was founded in 2005. |
| Where is Oxford Nanopore Technologies headquartered? | Oxford Nanopore Technologies is headquartered in United Kingdom. |
| How many employees does Oxford Nanopore Technologies have? | As of today, Oxford Nanopore Technologies has over 1K employees. |
| Who is the CEO of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' CEO is Gurdial Sanghera. |
| Is Oxford Nanopore Technologies publicly listed? | Yes, Oxford Nanopore Technologies is a public company listed on London Stock Exchange. |
| What is the stock symbol of Oxford Nanopore Technologies? | Oxford Nanopore Technologies trades under ONT ticker. |
| When did Oxford Nanopore Technologies go public? | Oxford Nanopore Technologies went public in 2021. |
| Who are competitors of Oxford Nanopore Technologies? | Oxford Nanopore Technologies main competitors are SKAN Group, Enovis, Haier Biomedical, PROCEPT BioRobotics. |
| What is the current market cap of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' current market cap is $1B. |
| What is the current revenue of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' last 12 months revenue is $312M. |
| What is the current revenue growth of Oxford Nanopore Technologies? | Oxford Nanopore Technologies revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Oxford Nanopore Technologies? | Current revenue multiple of Oxford Nanopore Technologies is 3.5x. |
| Is Oxford Nanopore Technologies profitable? | No, Oxford Nanopore Technologies is not profitable. |
| What is the current EBITDA of Oxford Nanopore Technologies? | Oxford Nanopore Technologies has negative EBITDA and is not profitable. |
| What is Oxford Nanopore Technologies' EBITDA margin? | Oxford Nanopore Technologies' last 12 months EBITDA margin is (59%). |
| What is the current EV/EBITDA multiple of Oxford Nanopore Technologies? | Current EBITDA multiple of Oxford Nanopore Technologies is (6.0x). |
| What is the current FCF of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' last 12 months FCF is ($120M). |
| What is Oxford Nanopore Technologies' FCF margin? | Oxford Nanopore Technologies' last 12 months FCF margin is (39%). |
| What is the current EV/FCF multiple of Oxford Nanopore Technologies? | Current FCF multiple of Oxford Nanopore Technologies is (9.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.